Company page

Genexine, Inc.

Genexine, Inc. is a public company listed on the Korea Stock Exchange under the ticker 095700. The company has a market capitalization of approximately 116.6 million USD. Genexine focuses on biopharmaceutical development, aiming to advance innovative therapies.

profile095700AI content: aiUpdated May 29, 2026/company/genexine-inc
Genexine, Inc. logo
Ticker
095700
Market cap
$116.6M
Sector
Health Technology
Industry
Biotechnology